Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.09% |
| Dec 31, 2025 | -47.93% |
| Sep 30, 2025 | -3.23% |
| Jun 30, 2025 | 2.86% |
| Mar 31, 2025 | -22.98% |
| Dec 31, 2024 | -3.98% |
| Sep 30, 2024 | 27.28% |
| Jun 30, 2024 | -149.90% |
| Mar 31, 2024 | -29.47% |
| Dec 31, 2023 | 20.55% |
| Sep 30, 2023 | 1.89% |
| Jun 30, 2023 | 14.76% |
| Mar 31, 2023 | 37.89% |
| Dec 31, 2022 | -59.04% |
| Sep 30, 2022 | 15.13% |
| Jun 30, 2022 | -24.22% |
| Mar 31, 2022 | -59.84% |
| Dec 31, 2021 | -40.26% |
| Sep 30, 2021 | 55.47% |
| Jun 30, 2021 | -95.64% |
| Mar 31, 2021 | 129.35% |
| Dec 31, 2020 | 88.42% |
| Sep 30, 2020 | -122.23% |
| Jun 30, 2020 | -128.03% |
| Mar 31, 2020 | -39.51% |
| Dec 31, 2019 | -62.18% |
| Sep 30, 2019 | -13.94% |
| Jun 30, 2019 | 27.46% |
| Mar 31, 2019 | 16.80% |
| Sep 30, 2018 | -70.88% |
| Jun 30, 2018 | -80.27% |
| Mar 31, 2018 | -51.93% |
| Dec 31, 2017 | -18.79% |
| Sep 30, 2017 | -122.26% |
| Jun 30, 2017 | 44.28% |
| Mar 31, 2017 | -15.36% |
| Dec 31, 2016 | 50.97% |
| Sep 30, 2016 | -157.13% |
| Jun 30, 2016 | -202.08% |
| Mar 31, 2016 | -58.71% |
| Dec 31, 2015 | -24.78% |
| Sep 30, 2015 | -44.96% |